However, downstream targets regulated by AMPK to confer its roles in PAH are not fully clarified yet; in addition, pharmacological modulation of AMPK is not entirely specific for AMPK and has off-target effects [20,21]. The gene discussed is PRKAA2; the disease is pulmonary arterial hypertension.